Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fontaine

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Patient Safety|May 26, 2022
Developing and Aligning a Safety Event Taxonomy for Inpatient PsychiatryTodd Barnes, Thomas Fontaine, Cynthia Bautista, et al.
Immunology Letters|November 17, 2010
Generation of anti-DC-SIGN monoclonal antibodies capable of blocking HIV-1 gp120 binding and reactive on formalin-fixed tissueBertrand Canard, Hortense Vachon, Thomas Fontaine, et al.
Experimental Dermatology|November 5, 2011
A new organotypic model containing dermal-type macrophagesNicolas Bechetoille, Hortense Vachon, Amandine Gaydon, et al.
Nature Communications|October 1, 2024
Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonistThomas Fontaine, Andreas Busch, Toon Laeremans, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Patient Safety|May 26, 2022
Developing and Aligning a Safety Event Taxonomy for Inpatient PsychiatryTodd Barnes, Thomas Fontaine, Cynthia Bautista, et al.
Immunology Letters|November 17, 2010
Generation of anti-DC-SIGN monoclonal antibodies capable of blocking HIV-1 gp120 binding and reactive on formalin-fixed tissueBertrand Canard, Hortense Vachon, Thomas Fontaine, et al.
Experimental Dermatology|November 5, 2011
A new organotypic model containing dermal-type macrophagesNicolas Bechetoille, Hortense Vachon, Amandine Gaydon, et al.
Nature Communications|October 1, 2024
Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonistThomas Fontaine, Andreas Busch, Toon Laeremans, et al.
Pageof 1